The FDA has approved Scholar Rock's new injectable treatment, Isembyld, for spinal muscular atrophy, marking a significant ...
Sun Pharmaceutical Industries has reached a settlement in a U.S. antitrust case regarding price-fixing practices in the ...
The Unit-IV operated by the company’s wholly owned subsidiary, Apitoria Pharma, was inspected from September 7 to September ...
The 18th BRICS Summit in New Delhi has paved the way for enhanced international cooperation in Traditional, Complementary, ...
Copenhagen: Novo Nordisk said on Monday that in a late-stage trial, 40.4% of children aged 6 to under 12 treated with semaglutide, the active ingredient in its blockbuster weight-loss drug Wegovy, ...
Opus Genetics' innovative eye drops enhance night vision for individuals with driving difficulties in low-light conditions.
AstraZeneca's breast cancer drug camizestrant, known as Etcamah, failed to improve progression-free survival in a late-stage ...
Novo Nordisk announces the termination of two heart drug trials for ziltivekimab, casting doubt on its diversification ...
Cipla has entered a licensing agreement to market Qil2107, a biosimilar of Keytruda in the US. The partnership aims to ...
GSK is shutting down its vaccine factory in Dresden, Germany by summer 2027 due to declining demand for traditional flu ...
Novartis' cholesterol drug pelacarsen fails to reduce heart attack and stroke risk in late-stage study, impacting investor ...
The Indian pharmaceutical industry opposes a new regulatory proposal that holds drug manufacturers accountable for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results